300 related articles for article (PubMed ID: 25957567)
1. Regulation of white adipogenesis and its relation to ectopic fat accumulation and cardiovascular risk.
Gustafson B; Smith U
Atherosclerosis; 2015 Jul; 241(1):27-35. PubMed ID: 25957567
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids.
Smith U; Kahn BB
J Intern Med; 2016 Nov; 280(5):465-475. PubMed ID: 27699898
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and impaired adipogenesis.
Gustafson B; Hedjazifar S; Gogg S; Hammarstedt A; Smith U
Trends Endocrinol Metab; 2015 Apr; 26(4):193-200. PubMed ID: 25703677
[TBL] [Abstract][Full Text] [Related]
4. Ectopic fat and cardiometabolic and vascular risk.
Lim S; Meigs JB
Int J Cardiol; 2013 Nov; 169(3):166-76. PubMed ID: 24063931
[TBL] [Abstract][Full Text] [Related]
5. Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response.
Klimcáková E; Roussel B; Márquez-Quiñones A; Kovácová Z; Kováciková M; Combes M; Siklová-Vítková M; Hejnová J; Srámková P; Bouloumié A; Viguerie N; Stich V; Langin D
J Clin Endocrinol Metab; 2011 Jan; 96(1):E73-82. PubMed ID: 21047918
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory characteristics of distinct abdominal adipose tissue depots relate differently to metabolic risk factors for cardiovascular disease: distinct fat depots and vascular risk factors.
Kranendonk ME; van Herwaarden JA; Stupkova T; de Jager W; Vink A; Moll FL; Kalkhoven E; Visseren FL
Atherosclerosis; 2015 Apr; 239(2):419-27. PubMed ID: 25682042
[TBL] [Abstract][Full Text] [Related]
7. Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity.
Hammarstedt A; Gogg S; Hedjazifar S; Nerstedt A; Smith U
Physiol Rev; 2018 Oct; 98(4):1911-1941. PubMed ID: 30067159
[TBL] [Abstract][Full Text] [Related]
8. Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications.
Longo M; Zatterale F; Naderi J; Parrillo L; Formisano P; Raciti GA; Beguinot F; Miele C
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31085992
[TBL] [Abstract][Full Text] [Related]
9. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
[TBL] [Abstract][Full Text] [Related]
10. Two Faces of White Adipose Tissue with Heterogeneous Adipogenic Progenitors.
Hwang I; Kim JB
Diabetes Metab J; 2019 Dec; 43(6):752-762. PubMed ID: 31902145
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
[TBL] [Abstract][Full Text] [Related]
12. Ectopic fat and cardiovascular disease: what is the link?
Gastaldelli A; Basta G
Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):481-90. PubMed ID: 20659791
[TBL] [Abstract][Full Text] [Related]
13. Under the Surface of Subcutaneous Adipose Tissue Biology.
Pandžić Jakšić V; Grizelj D
Acta Dermatovenerol Croat; 2016 Dec; 24(4):250-260. PubMed ID: 28128075
[TBL] [Abstract][Full Text] [Related]
14. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases.
Montani JP; Carroll JF; Dwyer TM; Antic V; Yang Z; Dulloo AG
Int J Obes Relat Metab Disord; 2004 Dec; 28 Suppl 4():S58-65. PubMed ID: 15592488
[TBL] [Abstract][Full Text] [Related]
15. The progression of cardiovascular risk to cardiovascular disease.
Rosin BL
Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
[TBL] [Abstract][Full Text] [Related]
16. What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?
Cuthbertson DJ; Steele T; Wilding JP; Halford JC; Harrold JA; Hamer M; Karpe F
Int J Obes (Lond); 2017 Jun; 41(6):853-865. PubMed ID: 28077863
[TBL] [Abstract][Full Text] [Related]
17. Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapy.
Ma X; Lee P; Chisholm DJ; James DE
Front Endocrinol (Lausanne); 2015; 6():1. PubMed ID: 25688231
[TBL] [Abstract][Full Text] [Related]
18. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.
Hajer GR; van Haeften TW; Visseren FL
Eur Heart J; 2008 Dec; 29(24):2959-71. PubMed ID: 18775919
[TBL] [Abstract][Full Text] [Related]
19. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
20. Ectopic fat: the true culprit linking obesity and cardiovascular disease?
Morelli M; Gaggini M; Daniele G; Marraccini P; Sicari R; Gastaldelli A
Thromb Haemost; 2013 Oct; 110(4):651-60. PubMed ID: 23884194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
